Featured Research

from universities, journals, and other organizations

Study Identifies Factors Associated With Long-term Opioid Treatment Of Veteran Patients

Date:
November 30, 2004
Source:
Journal Of The American Medical Association
Summary:
Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

CHICAGO -- Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

"The long-term use of opioids for the treatment of chronic pain of nonmalignant [noncancerous] origin has been generally supported by specialists in pain management as a less than ideal but often necessary and humane course of treatment," according to background information in the article. Long-term opioid use can by complicated by problematic dose increases, drug dependency, and toxic effects.

John A. Hermos, M.D., from Boston University School of Public Health, and colleagues analyzed pharmacy and clinical databases in order to determine characteristics of prescribing patterns and to identify potential high-risk opioid prescribing. Data on durations, doses, and dose changes of oxycodone/acetaminophen and concurrent use of long-acting opioids, benzodiazepines, tricyclic antidepressants, and anticonvulsants were obtained from the Veterans Integrated Service Network for the New England region (VISN 1) from January 1998 through June 2001.

The researchers found that during the study period, 47,302 patients received 177,840 prescriptions (initial and renewed prescriptions) for short-acting opioid medications, and 6,936 received 53,083 prescriptions for long-acting opioids. Two thousand one hundred ninety-five patients (31 percent with cancer) received oxycodone/acetaminophen for more than nine months at an average prescribed dose of 3.9 tablets per day, without significant changes in daily prescribed average dose over time. Patients with cancer were more likely to receive other long-acting opioids simultaneously. In those without cancer, high daily average doses were associated with duration, older age, HIV and/or AIDS, and with prescription of benzodiazepines and long-acting opioids.

"In veteran patients who received long-term oxycodone/acetaminophen prescriptions, mean daily doses were typically modest and stable, likely reflecting a selection of patients with successful, long-term management," the authors write. "Among patients without cancer, however, associations of higher oxycodone/acetaminophen doses with benzodiazepine prescriptions, psychogenic pain, alcohol abuse, and HIV/AIDS may portend opioid prescription management problems."

###

(Arch Intern Med. 2004;164:2361-2366. Available post-embargo at archinternmed.com)

Editor's Note: This study was funded by the Massachusetts Veterans Epidemiology Research Information Center (MAVERIC) from the Veterans Health Administration Cooperative Studies Program, Boston, Mass.


Story Source:

The above story is based on materials provided by Journal Of The American Medical Association. Note: Materials may be edited for content and length.


Cite This Page:

Journal Of The American Medical Association. "Study Identifies Factors Associated With Long-term Opioid Treatment Of Veteran Patients." ScienceDaily. ScienceDaily, 30 November 2004. <www.sciencedaily.com/releases/2004/11/041123113530.htm>.
Journal Of The American Medical Association. (2004, November 30). Study Identifies Factors Associated With Long-term Opioid Treatment Of Veteran Patients. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/11/041123113530.htm
Journal Of The American Medical Association. "Study Identifies Factors Associated With Long-term Opioid Treatment Of Veteran Patients." ScienceDaily. www.sciencedaily.com/releases/2004/11/041123113530.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins